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A direct rapid immunohistochemical test (dRIT) was
evaluated under field and laboratory conditions to detect
rabies virus antigen in frozen and glycerol-preserved field
brain samples from northwestern Tanzania. Compared to
the direct fluorescent antibody test, the traditional standard
in rabies diagnosis, the dRIT was 100% sensitive and spe-
cific.
I
n much of the developing world, rabies surveillance and
diagnosis in domestic and wild animals are severely
constrained. High ambient temperatures hinder the collec-
tion and preservation of fresh specimens. The use of the
direct fluorescent-antibody assay (DFA), the traditional
standard in rabies diagnosis (1,2), is limited by the costs of
acquiring and maintaining a fluorescent microscope.
Difficulties in obtaining diagnostic results from field mate-
rial have led to widespread underreporting of disease. 
Consequently, the true public health impact of rabies
has been greatly underestimated (3–5), and political com-
mitment for its control has been lacking. Moreover, the
absence of a confirmatory test can result in the inappropri-
ate management of animal bite injuries, with human deaths
a potential consequence of delays in rabies postexposure
prophylaxis (PEP) and unnecessary administration of PEP.
The latter is a particular concern, given the scarcity and
costs of human rabies vaccines and immunoglobulin in
many parts of the world.
A rapid immunohistochemical test (RIT) to detect
rabies virus (RABV) antigen has been developed in the
Rabies Section of the Centers for Disease Control and
Prevention (CDC) by incorporating various components of
existing immunoperoxidase techniques (6). Like the DFA,
the RIT is performed on brain touch impressions, but the
product of the reaction can be observed by light
microscopy, and RABV antigen appears as magenta inclu-
sions against a blue neuronal background. The test recog-
nizes all genotype 1 variants of RABV examined to date
and all representative lyssaviruses. Modifications of a for-
mer indirect test have led to a direct test (dRIT) that uses a
cocktail of highly concentrated and purified biotinylated
anti-nucleocapsid monoclonal antibodies produced in vitro
in a direct staining approach and allows a diagnosis to be
made in <1 hour. For the routine diagnosis of rabies, glyc-
erol saline is a convenient preservative in situations in
which refrigeration or freezing facilities are not promptly
available (7).
We report findings of a preliminary study to evaluate
the dRIT, comparing results of the dRIT carried out under
field conditions in Tanzania with the dRIT and DFA per-
formed at CDC. The objectives were to validate the dRIT
as a field test for rabies surveillance and evaluate the dRIT
on glycerol-preserved field samples.
The Study
Brain stem samples from various animal species were
obtained from December 2002 to September 2004 as a
result of rabies surveillance operations established in the
Mara, Mwanza, and Shinyanga regions of northwestern
Tanzania. Some archived glycerolated specimens were
also analyzed. Samples were collected by inserting a
drinking-straw through the occipital foramen, according to
World Health Organization recommendations (7) or by
opening the skull.
Some specimens were frozen (–20°C). Other samples
inside straws were placed into a solution of phosphate-
buffered 50% glycerol and stored either at +4°C or at
–20°C or kept at room temperature (25°C ± 5°C) for up to
4 months before refrigeration or freezing. 
Samples were allocated to 4 groups, according to the
method of preservation and whether the samples were test-
ed in the field and at the CDC laboratory or at CDC only
(Table 1). Group A samples were kept in glycerol solution
for <15 months and washed in phosphate-buffered saline
(PBS) before testing by dRIT in the field. They were then
stored at –20°C for <5 months and retransferred into fresh
glycerol for shipment. At CDC, the samples were kept in
glycerol for <2 months and rewashed in PBS before retest-
ing by both dRIT and DFA or DFA only. Group B samples
were stored frozen for <6 months, processed by dRIT in
the field, and placed into glycerol solution for shipment to
CDC, where they were stored for 2 months before being
washed in PBS and retested. Group C samples were pre-
served in glycerol solution for <60 months, shipped, and
processed at CDC by dRIT and DFAwithout previous test-
ing in the field. These samples were washed in PBS just
before testing. Group D samples were stored at –20°C in
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A qualitative assessment of the samples was made
before testing. Five specimens at a time were stained by
dRIT at ambient temperature as described below. Touch
impressions were made on glass microscope slides as
described (8). The slides were air-dried, fixed in 10%
buffered formalin for 10 min, dip-rinsed in wash buffer
PBS with 1% Tween 80 (TPBS), immersed in 3% hydro-
gen peroxide for 10 min, and dip-rinsed in fresh TPBS.
After dipping, the excess buffer was shaken from the
slides and blotted from the edges surrounding the impres-
sion. This treatment was repeated after each rinsing step.
The slides were incubated in a humidity chamber (a cover
on a moistened paper towel on an even surface) with the
MAb cocktail for 10 min, dip-rinsed in TPBS, incubated
with streptavidin-peroxidase complex (Kirkegaard and
Perry Laboratories, Inc., Gaithersburg, MD, USA) for 10
minutes and dipped in TPBS. A 3-amino-9-ethylcarbazole
(AEC) stock solution was prepared by dissolving one 20-
mg tablet AEC (Sigma-Aldrich Corp, St Louis, MO, USA)
in 4 mL N,N-dimethylformamide (Fisher Scientific
International, Inc., Pittsburgh, PA, USA) and stored at
4°C. A working dilution was prepared by adding 1 mL
AEC stock solution to 14 mL 0.1 mol/L acetate buffer
(Polyscientific, Bay Shore, NY, USA) and 0.15 mL 3%
hydrogen peroxide. The slides were incubated with the
AEC peroxidase substrate for 10 min and dip-rinsed in
distilled water. They were then counterstained with Gill’s
formulation #2 hematoxylin (Fisher Scientific
International) diluted 1:2 with distilled water for 2 min
and dip-rinsed in distilled water. Finally, they were mount-
ed with a water-soluble mounting medium (BioMeda
Corp., Foster City, CA, USA) and examined by light
microscopy (Leica Microsystems AG, Wetzlar, Germany)
in Tanzania and Axioplan 2 (Carl Zeiss AG, Göttingen,
Germany) at CDC at magnifications of ×200 to ×400. The
same operator performed the dRIT in the field and at
CDC. However, at CDC, identification numbers unknown
to the operator were assigned. The DFA (FITC Anti-
Rabies Monoclonal Globulin, Fujerebio Diagnostic Inc.,
Malvern, PA, USA)  was performed in a blind manner by
another operator as described (8) and read by fluoresent
microscopy (Axioplan 2).
Confidence intervals for the sensitivity and specificity
were calculated by using the exact binomial distribution
(S-Plus, Insightful Corp., Seattle, WA, USA). Of 159 total
samples tested, 59 specimens (37.1%) were positive for
RABV antigen, and 100 (62.9%) were negative by dRIT,
with 100% agreement between the tests, whether dRIT
was performed in field conditions only, both in field and
laboratory conditions, or in laboratory conditions only.
Assuming that the DFA was 100% sensitive and specific,
the dRIT was 100% sensitive (95% confidence interval
[CI] 93.9%–100.0%) and 100% specific (95% CI
96.3%–100.0%). Table 2 shows the distribution of positive
samples in the various animal species.
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ble, regardless of the method of preservation. We have no
evidence that storage times affected positivity because 34
(77.2%) of 44 samples stored in glycerol solution
remained positive for up to 10 months before being tested
in the field and retested at CDC after an interval of up to 6
months. Furthermore, RABV antigen was successfully
detected in the sample that had been preserved in glycerol
for the longest duration (15 months) before dRIT in the
field, stored frozen for 3 months before shipment to CDC,
and kept in glycerol for 2 months before being retested
(Figure 1). Similarly, viral inclusions were detected in a
sample stored frozen for 24 months, although the antigen
distribution was sparse with both tests. Our data do not
provide any unequivocal conclusions on test sensitivity
with samples preserved in glycerol solution for >15
months because results from all 15 archived brains were
negative. For these samples, the presence of antigen at the
time of collection cannot be excluded.
Four of 10 (40.0%) deteriorated specimens were posi-
tive (Figure 2). Among the 6 brains with negative results,
only 1 was suspected of containing rabies. The negative
finding might have been caused by inadequate preserva-
tion, since the sample had been stored in glycerol solution
at ambient temperature for up to 4 months before being
refrigerated.
Conclusions
The dRIT showed a sensitivity and specificity equiva-
lent to those of the DFA. The test is simple, requires no
specialized equipment or infrastructure, and can be suc-
cessfully performed on samples preserved in glycerol solu-
tion for 15 months or frozen for 24 months and in variable
conditions of preservation. These qualities make it ideal
for testing under field conditions and in developing coun-
tries. Although further laboratory and field evaluations are
required, our results are promising and highlight the poten-
tial value of the dRIT for countries with limited diagnostic
resources. First, this technique could greatly enhance epi-
demiologic surveillance in remote areas where rabies inci-
dence data are difficult to obtain. Second, the test could
improve the ability to respond to outbreaks with effective
management decisions. Third, it could be extremely valu-
able in guiding decisions regarding rational use of rabies
PEP.
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Figure 1. Touch impression of a rabies-positive Tanzanian domes-
tic dog brain preserved in 50% glycerol saline solution for 15
months before testing by direct rapid immunohistochemical test
(dRIT) and retested by direct fluorescent-antibody assay (DFA)
after 5 months. A) Brain stained by dRIT: rabies virus antigen
appears as magenta inclusions (arrowheads) against the blue
neuronal hematoxylin counterstain. Magnification, ×630. B)
Immunofluorescent apple-green viral inclusions in the same brain
processed by DFA. Magnification, ×200.
Figure 2. Touch impression of a deteriorated glycerolated brain
from a Tanzanian spotted hyena (Crocuta crocuta) with rabies. A)
Brain processed by direct rapid immunohistochemical test (dRIT).
Magnification, ×400. B) DFAstaining procedure on the same brain.
Magnification, ×200.Medicine for the early part of this work and by the UK
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